Biofilm-disrupting irrigation in established hip & knee prosthetic joint infection: a scoping review

Umair Khan1, Mesut Eren Enc1

  • 1Trauma and Orthopaedics, South Tees Hospital NHS Foundation Trust, TS4 3BW, UK.

Insights

Limited clinical evidence exists for biofilm-disrupting irrigation solutions in prosthetic joint infections (PJI). This review found no superior irrigant, highlighting the need for standardized trials in PJI surgery.

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Biomaterials Science

Background:

  • Biofilm formation on prosthetic joints is a primary cause of treatment failure in prosthetic joint infection (PJI).
  • Intraoperative irrigation is standard during PJI surgery, but evidence for specific biofilm-disrupting solutions is limited.
  • Established PJI treatment relies on surgical intervention, including debridement, antibiotics, and implant retention (DAIR) or revision.

Purpose of the Study:

  • To map clinical evidence on biofilm-disrupting irrigation strategies for established hip and knee PJI.
  • To identify existing evidence gaps regarding intraoperative irrigation in PJI surgery.
  • To evaluate the clinical outcomes associated with defined irrigation solutions beyond normal saline.

Main Methods:

  • A scoping review adhering to PRISMA-ScR guidelines.
  • Searches conducted in PubMed, Scopus, and Embase for clinical studies on established PJI.
  • Inclusion of studies reporting outcomes for defined biofilm-disrupting irrigation solutions during surgery.

Main Results:

  • Four retrospective studies met inclusion criteria, primarily evaluating povidone-iodine/hydrogen peroxide and vancomycin-povidone iodine protocols.
  • Some protocols showed potential for lower failure rates in specific cohorts, but results were variable.
  • One study indicated Bactisure® did not significantly reduce DAIR failure compared to standard irrigation.

Conclusions:

  • Current clinical evidence is insufficient to identify a superior biofilm-disrupting irrigant for established PJI.
  • Limitations include small study numbers, retrospective designs, and heterogeneous patient/treatment factors.
  • Future multicenter prospective trials are needed to evaluate standardized irrigation protocols within comprehensive treatment bundles.